Open Accessibility Menu
Hide

WMC Lung Cancer Program Achieves Two Firsts: Center of Excellence Designation, Robotic Bronchoscopy

WMC Lung Cancer Program Achieves Two Firsts: Center of Excellence Designation, Robotic Bronchoscopy

The GO2 Foundation for Lung Cancer has recognized Winchester Medical Center’s (WMC) thoracic oncology team for its commitment to providing patient-focused, coordinated and multidisciplinary care. Foundation representatives confirmed on November 12 that WMC has been designated a Care Continuum Center of Excellence (CCCE), the first hospital in Virginia to earn that designation.

Valley Health’s lung cancer program has also achieved another significant first. WMC has expanded advanced diagnostic capabilities for lung cancer with the launch of robot-assisted bronchoscopy using Intuitive Surgical’s ION™ Endoluminal System. The interventional pulmonology team performed the first robotic bronchoscopy using the ION technology on November 12. WMC is the first facility in the Mid-Atlantic region to have acquired the ION robotic platform. The U.S. Food and Drug Administration approved the ION system earlier this year to enable minimally invasive biopsy in difficult-to-reach peripheral areas of the lung.

Valley Health has one of the most comprehensive pulmonary/thoracic programs in the region for the diagnosis and minimally invasive treatment of lung cancer. Low dose CT lung screening is available at all Valley Health hospitals for adults with a history of smoking who are at high risk of lung cancer. The screening program has extended to include patients who have an incidental lung nodule found during routine or emergency imaging. Valley Health’s multidisciplinary Lung Nodule Clinic specializes in expediting the workup of patients with lung nodules or lesions and provides assessment and options for further testing and follow-up. The clinic’s team of pulmonary and thoracic specialists also includes physicians from specialties such as diagnostic radiology, interventional radiology, radiation oncology and medical oncology.

In addition to robot-assisted bronchoscopy/biopsy, interventional pulmonary specialists at WMC offer advanced means to diagnose lung cancer including electromagnetic navigational bronchoscopy and endobronchial ultrasound (EBUS). WMC’s thoracic specialists offer expertise in advanced surgical treatments including minimally invasive video-assisted thoracic surgery (VATS) and robot-assisted techniques using the da Vinci® XI™ Surgical System. Patients receiving lung cancer care at the Valley Health Cancer Center at WMC have access to a thoracic patient navigator who provides personalized support, information and resources. Patients also have access to treatment options such as advanced chemotherapy, radiation therapy and interventional radiology when indicated.

The GO2 Foundation for Lung Cancer identifies hospitals that meet rigorous qualifying criteria and works closely with staff to ensure the highest quality of multidisciplinary care with a patient-centric approach. Meeting the criteria for Care Continuum Center of Excellence provides patients with access to the latest innovations across the lung cancer care continuum not typically found in community hospitals. During their November 12 site visit to WMC, GO2 Foundation staff met with members of the thoracic oncology team to review Valley Health’s multidisciplinary approach to lung cancer care from screening to diagnosis and treatment to survivorship support. They noted that as a Care Continuum Center of Excellence, WMC has access to educational materials and resources for patients, clinical research and opportunities for networking with other CCCE hospitals.

The GO2 Foundation is the result of a 2019 merger between the two nonprofit organizations serving the lung cancer community, the Bonnie J. Addario Lung Cancer Foundation and Lung Cancer Alliance.

Thanks and congratulations to everyone involved in our thoracic oncology program for your commitment to providing high-quality care for our patients with lung cancer!